BOULDER - Array BioPharma Inc. is moving forward with clinical trials for its oral drug for Type 2 diabetes based on promising preclinical data. Boulder-based Array (Nasdaq:ARRY) said the data on ARRY-403, a small molecule glucokinase activator ... ...